H-1B sponsorship profile: Amicus Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Amicus Therapeutics, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Amicus Therapeutics, Inc’s H-1B petitions range from $99,488 at the low end to $102,939 at the high end, with a petition-weighted average of $100,638. That range reflects the mix of occupations the company sponsors, led by Program Manger (2 petitions at $99,488 avg), followed by Project Management Specialist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Amicus Therapeutics, Inc is headquartered in Philadelphia, PA under NAICS code 325412, and places H-1B workers across 2 states, most heavily in NY, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Amicus Therapeutics, Inc ranks. By H-1B petition volume, Amicus Therapeutics, Inc is #37,433 of 119,880 employers nationally and #1,111 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.